Paid Clinical Trials Nevada
Discover 521 paid clinical trials in Nevada. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Danvatirsen & PembrolizumabActivity and Safety of Danvatirsen and Pembrolizumab in HNSCC
Sponsor:
Flamingo Therapeutics NV
Location:
Code:
NCT05814666
Conditions
HNSCC
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Danvatirsen
Pembrolizumab
Rexlemestrocel-L & HAEfficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain
Sponsor:
Mesoblast, Ltd.
Location:
Code:
NCT06325566
Conditions
Degenerative Disc Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Rexlemestrocel-L + HA mixture
Saline
GSK4172239DA Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years
Sponsor:
GlaxoSmithKline
Location:
Code:
NCT05660265
Conditions
Hematologic Diseases
Anaemia, Sickle Cell
Eligibility Criteria
Sex: All
Age: 18 - 50
Healthy Volunteers: Not accepted
Interventions
GSK4172239D
Placebo
RimegepantA Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Sponsor:
Pfizer
Location:
Code:
NCT06641466
Conditions
Menstrual Migraine
Eligibility Criteria
Sex: Female
Age: 18 - 45
Healthy Volunteers: Not accepted
Interventions
Rimegepant
Placebo Comparator
Standard of Care
Lasofoxifene & FulvestrantEvaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Sponsor:
Sermonix Pharmaceuticals Inc.
Location:
Code:
NCT05696626
Conditions
Metastatic Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Lasofoxifene in combination with abemaciclib
Fulvestrant in combination with abemaciclib
LenalidomideMCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients
Sponsor:
St. Joseph's Hospital and Medical Center, Phoenix
Location:
Code:
NCT04032626
Conditions
Cognitive Impairment, Mild
Cognitive Dysfunction
Amyloid Plaque
Neurodegeneration
Inflammation, Brain
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Not accepted
Interventions
Lenalidomide 10 mg
Placebo
Combination ChemotherapyCombination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
Sponsor:
University of Leicester
Location:
Code:
NCT00020566
Conditions
Sarcoma
Eligibility Criteria
Sex: All
Age: 0 - 49
Healthy Volunteers: Not accepted
Interventions
dactinomycin
busulfan
doxorubicin hydrochloride
etoposide
ifosfamide
PegozaferminA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Sponsor:
89bio, Inc.
Location:
Code:
NCT06419374
Conditions
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Pegozafermin
Placebo
Cortical ModulationModulating Cortical Excitability to Improve Functional Movements in Individuals With Patellofemoral Pain
Sponsor:
University of Nevada, Las Vegas
Location:
Code:
NCT06565520
Conditions
Patellofemoral Pain Syndrome
Eligibility Criteria
Sex: All
Age: 18 - 45
Healthy Volunteers: Not accepted
Interventions
transcranial direct current stimulator